Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 8 recruiting now small index

Speech clinical trials

8 of 10 indexed Speech trials are currently recruiting.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

10 US clinical trials · 8 currently recruiting · #1,724 of 28,707 conditions by registered trial count

Speech: 10 US clinical trials tracked, 8 recruiting.

Speech is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. The most active sponsor is Yale University, running 3 of these trials.

Enrollment posture brief

Registry condition speech

OPEN 8 | RECR 80% | LATE 0 | EARLY 0 | RANK #1724 | SPON 3

Nearest open-share peer: Ablation (80% recruiting · 5 trials)

Acute Leukemia of Ambiguous 80%Speech (this)80%Achondroplasia40%Accelerated Phase Chronic My20%Accidental Fall20%
Open-enrollment share among volume-matched conditions near Speech

Speech lists 8 open slots (80% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Speech on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Speech is recruiting above its size-band peers.

    8 of 10 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Speech research.

    Yale University accounts for 3 of 10 trials (30%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Speech enrolment sits around 120 participants.

    Median target enrolment is 120 among the 10 trials that report a genuine target (sentinel values excluded). 4 of those (40%) plan for fewer than 100 participants.

  4. Speech research is mostly interventional.

    9 interventional and 1 observational studies make up this index (90% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Speech records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Adaptation Behavioral
3 trials
continuous theta-burst stimulation (cTBS) Device
2 trials
Thinking in Speech Behavioral
1 trials
DNA Analysis Genetic
1 trials
Questionnaires and Clinical Assessments Behavioral
1 trials
Voice, Speech and Language Analysis Behavioral
1 trials
Cognitive Battery Diagnostic test
1 trials
Single pulse Transcranial magnetic stimulation (TMS) Device
1 trials

US sites by state

Facility locations filed on Speech trials. A trial with sites in several states counts in each.

Connecticut 3 trials
West Virginia 1 trials
Wisconsin 1 trials
Washington 1 trials
Utah 1 trials
Pennsylvania 1 trials
Massachusetts 1 trials
Kansas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Speech page

10 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Speech condition card totals 10 registered trials; most-linked intervention Adaptation; top US site state Connecticut. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.